Inside informationEnglish
BIOPHYTIS ANNOUNCES APPROVAL OF THE OBA CLINICAL TRIAL IN BRAZIL AND SHARES ITS OUTLOOK FOR BIO101 IN OBESITY
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Biophytis
- Filed
- 10/08/2026, 06:59
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 082966_20260810